Seattle regimen RIC-HSCT in early-phase multiple myeloma: a multi-centre experience demonstrating very low treatment-related mortality and rapid graft-versus-myeloma effect associated with graft-versus-host disease.
Shipton, Michael J Routledge, David J Bodagh, N Cavet, James Tholouli, E Kulkarni, Samar Gibbs, S
Shipton, Michael J
Routledge, David J
Bodagh, N
Cavet, James
Tholouli, E
Kulkarni, Samar
Gibbs, S
Citations
Altmetric:
Abstract
Description
Date
2015
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Seattle regimen RIC-HSCT in early-phase multiple myeloma: a multi-centre experience demonstrating very low treatment-related mortality and rapid graft-versus-myeloma effect associated with graft-versus-host disease. 2015, 126 (23): Blood